Lexicon Pharmaceuticals | LXRX - 税前利润

股票价格
1.72
每天变化
0.08 4.88%
每月一次
14.67%
每年
381.66%
Q1 预测
1.51


金融业
股票价格
USD
资产
USD 184.99M
现金及等价物
USD 21.36M
销售成本
USD 201K
流动资产
USD 101.9M
流动负债
USD 20.87M
债务
USD 99.51M
股息收益率
0
EBIT
USD -14.78M
EBITDA
USD -12.04M
员工
285
EPS每股收益
USD -0.04
股本和储备
USD 107.54M
销售毛利
USD 5.29M
债务利息支出
USD 2.03M
贷款资金
USD 49.41M
市值
USD 401.4M
净收入
USD -15.53M
营业费用
USD 20.27M
营业利润
USD -14.78M
普通股股本
USD 363.47M
PE价格收益
12.44
税前利润
USD -12.77M
销售收入
USD 5.49M
销售和管理费用
USD 3.99M
股票
USD 168K
贸易债权人
USD 3.08M
应收帐款人
USD 2.38M


税前利润 更改 日
Abbott USD 2.36B 178M 2025-12
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
AstraZeneca USD 3.24B 117M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Coherus Biosciences USD -46.35M 90.86M 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Esperion Therapeutics USD 63.67M 95M 2025-12
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Illumina USD 220M 86M 2025-09
Insmed USD -326.93M 41.77M 2025-12
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
J&J USD 4.97B 2.53B 2025-12
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
MacroGenics USD -14.93M 31.75M 2025-12
MannKind USD -20.93M 28.71M 2025-12
Merck USD 6.74B 22M 2025-09
Moderna USD -187M 631M 2025-09
Novartis USD 4.64B 445M 2025-12
PTC Therapeutics USD -139.08M 116.01M 2025-12
Puma Biotechnology USD 20.61M 24.76M 2024-09
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
United Therapeutics USD 444M 6M 2025-12
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12